Sec Form 3 Filing - Neder Shiri @ NICE Ltd. - 2026-03-18

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Neder Shiri 2. Issuer Name and Ticker or Trading Symbol NICE Ltd. [ NICE] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) EVP, Human Resources (Last) (First) (Middle) 221 RIVER STREET 3. Date of Earliest Transaction (MM/DD/YY) 03/18/2026 (Street) HOBOKEN, NJ07030 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Options $ 0.307 ( 1 ) 03/03/2027 Ordinary Shares 1,800 D Options $ 0.3142 ( 1 ) 02/16/2028 Ordinary Shares 3,750 D Options $ 0.307 ( 1 ) 03/03/2028 Ordinary Shares 1,200 D Options $ 0.3142 ( 1 ) 02/16/2029 Ordinary Shares 2,500 D Options $ 0.273 ( 2 ) 02/22/2029 Ordinary Shares 9,150 D Options $ 0.2718 ( 3 ) 02/21/2030 Ordinary Shares 9,150 D Options $ 0.273 ( 4 ) 02/22/2030 Ordinary Shares 6,100 D Options $ 0.2706 ( 5 ) 06/01/2030 Ordinary Shares 4,800 D Options $ 0.2718 ( 6 ) 02/21/2031 Ordinary Shares 6,100 D Options $ 0.2824 ( 7 ) 02/19/2031 Ordinary Shares 10,000 D Options $ 0.2706 ( 8 ) 06/01/2031 Ordinary Shares 3,200 D Options $ 0.3228 ( 9 ) 02/18/2032 Ordinary Shares 12,500 D Options $ 0.2824 ( 10 ) 02/19/2032 Ordinary Shares 10,000 D Options $ 0.3228 ( 11 ) 02/18/2033 Ordinary Shares 10,000 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Neder Shiri 221 RIVER STREET HOBOKEN, NJ07030 EVP, Human Resources Signatures /s/ Alon Levy, Attorney-in-Fact for Shiri Neder 03/18/2026 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The stock option is fully vested and currently exercisable. ( 2 )The stock option is vested and exercisable with respect to 6,862 Ordinary Shares and will vest with respect to the remaining shares on February 22, 2027. ( 3 )The stock option is vested and exercisable with respect to 4,575 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 21, 2027 and February 21, 2028. ( 4 )The stock option is vested and exercisable with respect to 4,575 Ordinary Shares and will vest with respect to the remaining shares on February 22, 2027. ( 5 )The stock option is vested and exercisable with respect to 2,400 Ordinary Shares and will vest with respect to the remaining shares on June 1, 2027. ( 6 )The stock option is vested and exercisable with respect to 3,050 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 21, 2027 and February 21, 2028. ( 7 )The stock option is vested and exercisable with respect to 2,500 Ordinary Shares and will vest with respect to the remaining shares in three substantially equal installments on February 19, 2027, February 19, 2028 and February 19, 2029. ( 8 )The stock option is vested and exercisable with respect to 1,600 Ordinary Shares and will vest with respect to the remaining shares on June 1, 2027. ( 9 )The stock option will vest in substantially equal installments on February 18, 2027, February 18, 2028, February 18, 2029 and February 18, 2030. ( 10 )The stock option is vested and exercisable with respect to 2,500 Ordinary Shares and will vest with respect to the remaining shares in substantially equal installments on February 19, 2027, February 19, 2028 and February 19, 2029 ( 11 )Each Option represents a contingent right to receive one Ordinary Share of the Issuer. The Options are eligible to vest over a three-year performance period ending February 18, 2029, subject to adjustments in accordance with the terms of the awards, based upon the Issuer?s achievement of specified stock price performance thresholds.

Remarks: Exhibit 24 - Power of Attorney.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.